Ikemoto M - Search Results

1

Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis.

Kimura M, Tatsumi KI, Tada H, Izumi Y, Kaneko A, Kato M, Masuzawa M, Ikemoto M, Yabusaki Y, Hidaka Y, Amino N. Kimura M, et al. Among authors: ikemoto m. Clin Chim Acta. 2002 Feb;316(1-2):155-64. doi: 10.1016/s0009-8981(01)00747-1. Clin Chim Acta. 2002. PMID: 11750286

2

[Differential diagnosis of hepatitis: development of new laboratory tests for autoimmune hepatitis and progress in pathophysiology].

Amino N, Kimura M, Tanaka S, Izumi Y, Ikemoto M, Tatsumi KI, Takano T, Hidaka Y. Amino N, et al. Among authors: ikemoto m. Rinsho Byori. 2004 Jan;52(1):44-50. Rinsho Byori. 2004. PMID: 14968559 Japanese.

3

Enzyme immunoassay for autoantibodies to human liver-type arginase and its clinical application.

Kimura M, Tatsumi KI, Tada H, Ikemoto M, Fukuda Y, Kaneko A, Kato M, Hidaka Y, Amino N. Kimura M, et al. Among authors: ikemoto m. Clin Chem. 2000 Jan;46(1):112-7. Clin Chem. 2000. PMID: 10620579 Clinical Trial.

4

Enzyme immunoassay of liver-type arginase and its potential clinical application.

Ikemoto M, Ishida A, Tsunekawa S, Ozawa K, Kasai Y, Totani M, Ueda K. Ikemoto M, et al. Clin Chem. 1993 May;39(5):794-9. Clin Chem. 1993. PMID: 8387407

5

Liver-type arginase in serum during and after liver transplantation: a novel index in monitoring conditions of the liver graft and its clinical significance.

Ikemoto M, Tsunekawa S, Tanaka K, Tanaka A, Yamaoka Y, Ozawa K, Fukuda Y, Moriyasu F, Totani M, Kasai Y, Mori T, Ueda K. Ikemoto M, et al. Clin Chim Acta. 1998 Mar 9;271(1):11-23. doi: 10.1016/s0009-8981(97)00226-x. Clin Chim Acta. 1998. PMID: 9564554

6

Identification of serum proteins that bind with S100A8, S100A9 and S100A8/A9: clinical significance of using proteins for monitoring the postoperative condition of liver recipients.

Namura T, Arai S, Okawa K, Koike A, Yamada S, Saita N, Nagae A, Itoh H, Totani M, Uemoto S, Ikemoto M. Namura T, et al. Among authors: ikemoto m. Clin Chim Acta. 2010 Nov 11;411(21-22):1766-73. doi: 10.1016/j.cca.2010.07.029. Epub 2010 Jul 30. Clin Chim Acta. 2010. PMID: 20674560 Free article.

7

Advantage of serum type-I arginase and ornithine carbamoyltransferase in the evaluation of acute and chronic liver damage induced by thioacetamide in rats.

Murayama H, Ikemoto M, Fukuda Y, Tsunekawa S, Nagata A. Murayama H, et al. Among authors: ikemoto m. Clin Chim Acta. 2007 Jan;375(1-2):63-8. doi: 10.1016/j.cca.2006.06.018. Epub 2006 Jun 21. Clin Chim Acta. 2007. PMID: 16872590

8

A sensitive ELISA for serum ornithine carbamoyltransferase utilizing the enhancement of immunoreactivity at alkaline pH.

Murayama H, Igarashi M, Mori M, Fukuda Y, Ikemoto M, Nagata A. Murayama H, et al. Among authors: ikemoto m. Clin Chim Acta. 2006 Jun;368(1-2):125-30. doi: 10.1016/j.cca.2005.12.017. Epub 2006 Jan 30. Clin Chim Acta. 2006. PMID: 16445902

9

Development of enzyme-linked immunosorbent assay for acidic fibroblast growth factor and its clinical application.

Ikemoto M, Hasegawa K, Kihara Y, Iwakura A, Komeda M, Yamazato A, Fujita M. Ikemoto M, et al. Clin Chim Acta. 1999 May;283(1-2):171-82. doi: 10.1016/s0009-8981(99)00045-5. Clin Chim Acta. 1999. PMID: 10404741 Clinical Trial.

10

Liver-type arginase is a highly sensitive marker for hepatocellular damage in rats.

Ikemoto M, Tsunekawa S, Toda Y, Totani M. Ikemoto M, et al. Clin Chem. 2001 May;47(5):946-8. Clin Chem. 2001. PMID: 11325904 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters